Inflammatory Disease News and Research

RSS

Researchers demonstrate the immunological effects of ginseng

Researchers writing in BioMed Central's open access Journal of Translational Medicine have shown that the herb, much used in traditional Chinese and other Asian medicine, does have anti-inflammatory effects.

13 May 2009

Radical blow for snotty arteries

Controlling the green stuff in snot could help treat heart disease, reveals Professor Michael Davies from the University of Sydney Faculty of Medicine and the Heart Research Institute.

12 May 2009

Image-guided treatment helping women with tubo-ovarian abscesses avoid unnecessary surgery

Image guided drainage of tubo ovarian abscesses help women avoid surgery, according to a study performed at Massachusetts General Hospital in Boston, MA.

23 Apr 2009

Immune cell type controls onset and course of severe malaria

Scientists have determined that a subset of immune cells may cause malaria patients to contract the severe form of the disease, suffering worse symptoms.

23 Apr 2009

Even modest exercise improves insulin sensitivity, decreases fat in the liver and inflammation in belly fat

A new University of Illinois study suggests that moderate amounts of exercise alone can reduce the inflammation in visceral fat - belly fat, if you will - that has been linked with metabolic syndrome, a group of risk factors that predict heart disease and Type 2 diabetes.

23 Apr 2009

Researchers identify mechanism by which an anti-TNF therapy impairs host defense against tuberculosis

The life of many individuals with inflammatory diseases such as rheumatoid arthritis has been dramatically improved by treatment with drugs that target the protein TNF, so called anti-TNF therapies.

20 Apr 2009

Health Canada approves Simponi (golimumab) for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

Centocor Ortho Biotech Inc. and Schering-Plough Corporation has announced that Health Canada has granted approval of Simponi (golimumab) as a once-monthly, subcutaneous therapy for the treatment of moderately to severely active rheumatoid arthritis (RA), active psoriatic arthritis (PsA) and active ankylosing spondylitis (AS).

13 Apr 2009

Research sheds new light on inflammatory disease

Scientists at the University of Liverpool have found that understanding the precise timing of communication between cells that coordinate the body's response to disease could be key to new drug developments.

12 Apr 2009

Scientists discover the secrets of NF-kappaB

A study published in Science examines a key player in conditions such as cancer, inflammatory bowel disease, rheumatoid arthritis and asthma and has shown that cells use a sophisticated communication system to coordinate responses to infection and maintain inflammation in the body.

12 Apr 2009

Vitamin D deficiency is associated with inflammation in healthy women

According to a recent study in the Archives of Internal Medicine, 75 percent of Americans do not get enough Vitamin D.

9 Apr 2009

Inflammatory chemokine may explain diseases that come with obesity

An inflammatory factor already linked to several diseases, including pulmonary disease, lung cancer, and arthritis, may also be responsible for the insulin resistance that comes with obesity, according to a new study published in the April issue of Cell Metabolism.

8 Apr 2009

Discovery of gene variant associated with increased risk of atopic dermatitis

Scientists of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Charité - University Medical School, Berlin, Germany, in collaboration with researchers from the Klinikum rechts der Isar of Technical University Munich and Christian Albrecht University, Kiel, have identified a gene variant on chromosome 11 that is associated with an increased risk of atopic dermatitis.

6 Apr 2009

New family of biologically active products of omega-3 fatty acids show potential to resolve periodontal inflammation

Periodontal (gum) disease is a chronic inflammation initiated by bacteria that affect the gums and bone supporting the teeth, and may eventually result in tissue and tooth loss.

6 Apr 2009

Sagent Pharmaceuticals receives FDA approval of Azithromycin for injection

Sagent Pharmaceuticals, Inc. has announced U.S. Food and Drug Administration (FDA) approval of azithromycin for injection, a semi-synthetic, macrolide antibiotic that is used to treat a wide variety of bacterial infections. Sagent will offer azithromycin in a 500 mg vial for intravenous use.

26 Mar 2009

Merck Serono launches strategic venture capital fund

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the formation of 'Merck Serono Ventures', a strategic, corporate venture capital fund to invest in emerging biotechnology companies.

23 Mar 2009

Tobacco for drug synthesis

Tobacco isn't famous for its health benefits. But now scientists have succeeded in using genetically modified tobacco plants to produce medicines for several autoimmune and inflammatory diseases, including diabetes. The research is published in the open access journal BMC Biotechnology.

20 Mar 2009

Inflammatory Disease News and Research

Researchers demonstrate the immunological effects of ginseng

Radical blow for snotty arteries

Image-guided treatment helping women with tubo-ovarian abscesses avoid unnecessary surgery

Immune cell type controls onset and course of severe malaria

Even modest exercise improves insulin sensitivity, decreases fat in the liver and inflammation in belly fat

Researchers identify mechanism by which an anti-TNF therapy impairs host defense against tuberculosis

Health Canada approves Simponi (golimumab) for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

Research sheds new light on inflammatory disease

Scientists discover the secrets of NF-kappaB

Vitamin D deficiency is associated with inflammation in healthy women

Inflammatory chemokine may explain diseases that come with obesity

Discovery of gene variant associated with increased risk of atopic dermatitis

New family of biologically active products of omega-3 fatty acids show potential to resolve periodontal inflammation

Sagent Pharmaceuticals receives FDA approval of Azithromycin for injection

Merck Serono launches strategic venture capital fund

Tobacco for drug synthesis

Alba Therapeutics announces next clinical trial of lead compound, Larazotide Acetate

Discovery may lead to immunosuppressant drugs that have fewer adverse side effects

BioCis Pharma starts trial of novel topical drug for dermatology

A blood test for Alzheimer's on the horizon

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News